KP
Kaveri Pohlman Clear Street Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
38%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $25 |
100%
upside
| 1 | +2.7% |
0
%
| 25 Nov ‘25 2 days ago |
|
|
|
Buy
Maintained
| $21 |
58%
upside
| 1 | +16% |
0
%
| 14 Nov ‘25 13 days ago |
|
|
|
Buy
Initiated
| $18 |
374%
upside
| 1 | -18% |
0
%
| 13 Nov ‘25 14 days ago |
|
|
|
Buy
Initiated
| $29 |
310%
upside
| 1 | -9% |
0
%
| 22 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $60 |
80%
upside
| 2 | +13% |
0
%
| 21 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $11 |
10%
upside
| 1 | +221% |
0
%
| 1 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $46 |
51%
upside
| 1 | +104% |
0
%
| 17 Sep ‘25 2 months ago |
|